EQS-News: Dermapharm Holding SE
/ Key word(s): Annual Results/Annual Report
Successful financial year 2024: Dermapharm increases revenue and exceeds EBITDA guidance
28.03.2025 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.Read More
You might also be interested in reading XRP Surges 14%, Nears $1.70 Level Last Seen in April 2021.